Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gavin I Welsh

Showing results (101-110 of 109) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 109 results.
Pediatric Nephrology (Berlin, Germany)|February 25, 2022
Exploring the relevance of NUP93 variants in steroid-resistant nephrotic syndrome using next generation sequencing and a fly kidney modelAgnieszka Bierzynska, Katherine Bull, Sara Miellet, et al.
Cancer Cell|December 17, 2011
WT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicingElianna M Amin, Sebastian Oltean, Jing Hua, et al.
Kidney International|January 25, 2017
Genomic and clinical profiling of a national nephrotic syndrome cohort advocates a precision medicine approach to disease managementAgnieszka Bierzynska, Hugh J McCarthy, Katrina Soderquest, et al.
Cell Metabolism|October 5, 2010
Insulin signaling to the glomerular podocyte is critical for normal kidney functionGavin I Welsh, Lorna J Hale, Vera Eremina, et al.
Cardiovascular Diabetology|February 2, 2024
Heparanase inhibition as a systemic approach to protect the endothelial glycocalyx and prevent microvascular complications in diabetesMonica Gamez, Hesham E Elhegni, Sarah Fawaz, et al.
Clinical Kidney Journal|August 13, 2024
National Unified Renal Translational Research Enterprise: Idiopathic Nephrotic Syndrome (NURTuRE-INS) studyElizabeth Colby, Samantha Hayward, Melissa Benavente, et al.
Cardiovascular Diabetology|February 20, 2024
Correction: Heparanase inhibition as a systemic approach to protect the endothelial glycocalyx and prevent microvascular complications in diabetesMonica Gamez, Hesham E Elhegni, Sarah Fawaz, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 21, 2020
A role for NPY-NPY2R signaling in albuminuric kidney diseaseAbigail C Lay, A Fern Barrington, Jenny A Hurcombe, et al.
Med (New York, N.Y.)|October 20, 2023
Shiga toxin targets the podocyte causing hemolytic uremic syndrome through endothelial complement activationEmily E Bowen, Jennifer A Hurcombe, Fern Barrington, et al.
Pageof 11

Showing results (101-110 of 109) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 109 results.
Pediatric Nephrology (Berlin, Germany)|February 25, 2022
Exploring the relevance of NUP93 variants in steroid-resistant nephrotic syndrome using next generation sequencing and a fly kidney modelAgnieszka Bierzynska, Katherine Bull, Sara Miellet, et al.
Cancer Cell|December 17, 2011
WT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicingElianna M Amin, Sebastian Oltean, Jing Hua, et al.
Kidney International|January 25, 2017
Genomic and clinical profiling of a national nephrotic syndrome cohort advocates a precision medicine approach to disease managementAgnieszka Bierzynska, Hugh J McCarthy, Katrina Soderquest, et al.
Cell Metabolism|October 5, 2010
Insulin signaling to the glomerular podocyte is critical for normal kidney functionGavin I Welsh, Lorna J Hale, Vera Eremina, et al.
Cardiovascular Diabetology|February 2, 2024
Heparanase inhibition as a systemic approach to protect the endothelial glycocalyx and prevent microvascular complications in diabetesMonica Gamez, Hesham E Elhegni, Sarah Fawaz, et al.
Clinical Kidney Journal|August 13, 2024
National Unified Renal Translational Research Enterprise: Idiopathic Nephrotic Syndrome (NURTuRE-INS) studyElizabeth Colby, Samantha Hayward, Melissa Benavente, et al.
Cardiovascular Diabetology|February 20, 2024
Correction: Heparanase inhibition as a systemic approach to protect the endothelial glycocalyx and prevent microvascular complications in diabetesMonica Gamez, Hesham E Elhegni, Sarah Fawaz, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 21, 2020
A role for NPY-NPY2R signaling in albuminuric kidney diseaseAbigail C Lay, A Fern Barrington, Jenny A Hurcombe, et al.
Med (New York, N.Y.)|October 20, 2023
Shiga toxin targets the podocyte causing hemolytic uremic syndrome through endothelial complement activationEmily E Bowen, Jennifer A Hurcombe, Fern Barrington, et al.
Pageof 11